What Can We Tell Our Patients About Rheumatoid Arthritis Risk?
Canadian Rheumatology Today · 2025
DOI: 10.58931/crt.2025.2265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Rheumatology Today, 2025. Verfasst von Liam O’Neil und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
You are seeing a 45-year-old female with a chief complaint of joint pain in the hands and feet. The symptoms have been apparent for 6 months. There was no preceding illness. She reports morning stiffness of the affected joints. The patient denies any joint swelling. Her medical history is notable for a strong family history of Rheumatoid Arthritis, and she currently smokes one pack of cigarettes daily. On physical examination, the joints appear normal, with full range of motion and no obvious tenderness to palpation. There is no evidence of synovitis or rashes. Laboratory investigations show elevated anti-citrullinated protein antibody level of 135, and her rheumatoid factor level is 45. C-reactive protein is within normal limits. Radiographs of the hands and feet are normal. Questions: 1. What is her likelihood of developing rheumatoid arthritis within the next 3 years? 2. Are there any other tests you need to order? 3. Can rheumatoid arthritis be prevented in this individual? What advice can you provide her?
Zitieren
APA
O’Neil, L., & El-Gabalawy, H. (2025). What Can We Tell Our Patients About Rheumatoid Arthritis Risk?. Canadian Rheumatology Today. https://doi.org/10.58931/crt.2025.2265
Vancouver
O’Neil L, El-Gabalawy H. What Can We Tell Our Patients About Rheumatoid Arthritis Risk?. Canadian Rheumatology Today. 2025. doi:10.58931/crt.2025.2265
BibTeX
@article{ONeil2025,
author = {O’Neil, Liam and El-Gabalawy, Hani},
title = {What Can We Tell Our Patients About Rheumatoid Arthritis Risk?},
journal = {Canadian Rheumatology Today},
year = {2025},
doi = {10.58931/crt.2025.2265}
}
EUVIMED